点击这里给我发消息

关闭在线客服
电话:010-52831556
English
联系方式
中国疫苗行业协会

地址:北京市东城区新中

街11号1号楼5层

电话:010-52831556
网址:www.cav.org.cn
English
首页 >>English > English

BRIEF INTRODUCTION OF CHINA PHARMACEUTICAL ENTERPRISES DEVELOPMENT PROMOTE ASSOCIATION


On September 2, 2019, the Ministry of Civil Affairs approved the Chinese pharmaceutical Enterprise Development Promotion Association to change its name to the China Association for Vaccines to play a more active role in promoting the strengthening of vaccine industry self-discipline and guiding enterprises to carry out production and operation according to law.

China Association for Vaccines, CAV is according to the people's Republic of China vaccine management law under, and on reform and perfect vaccine management system of views under (Development Office of the CPC Central Committee issued [2018] No.70) spirit, in national industry, and market regulatory general, and SFDA, and health, and SASAC, and Ministry of civil affairs, 6 Ministries led and under Guide corporate status.

The purpose of the association is to serve the Health China strategy, adhere to the people as the center, always put the people's health in the first place development concept, promote the development of the vaccine and Related Biological Products industry. Actively participate in industry safety management, establish and improve industry self-regulatory norms, promote the construction of industry Credit System, Guide and supervise enterprises to carry out production and management activities according to the law, promote the whole industry self-management, self-regulation, self-purification, self-improvement. Strengthen communication and coordination between industry and government, promote the implementation of industrial policies and relevant laws and regulations, safeguard the legitimate rights and interests of members, maintain fair competition and market order, and actively promote scientific and technological innovation, optimize the allocation of resources, improve product and service quality, and promote industrial upgrading.

Association now has existing member units of 164, mainly in the development of vaccines and biological products, production, distribution and upstream and downstream related services supporting enterprises, throughout the whole industrial chain of biopharmaceutical.